# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 5
- Domains: 25
- Accuracy: 13/25 (52.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 65.53 |
| 20579848 | Palacios 2009 | 2/5 | 40.0% | 59.54 |
| 21775755 | Ziegler 2011 | 3/5 | 60.0% | 56.46 |
| 22928960 | Houry 2012 | 2/5 | 40.0% | 51.51 |
| 23148458 | Sheridan 2012 | 3/5 | 60.0% | 49.97 |

## Error Types

- under-called_due_to_missing_or_underused_evidence: 8
- over-inferred_from_sparse_reporting: 3
- blinding_outcome_type_or_role_confusion: 1

## 19487623 - King 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 65.53

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not reported
- `blinding_personnel`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.
- `blinding_outcome_assessors`: The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. "For subjects who failed to complete all postrandomization assessments, the last observation was carried forward."
- `study_design`: Randomized controlled trial (parallel-group), placebo-controlled, multi-site
- `additional_notes`: Liquid citalopram (Celexa, 10 mg/5 mL) was obtained commercially. Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. The trial, NCT00086645, was registered at clinicaltrials.gov before initiation and was conducted at 6 academic medical centers. All efficacy and safety analyses used the intent-to-treat principle.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The authors explicitly report a random component (permuted blocks with randomly varying block sizes stratified by site and age), which constitutes adequate random sequence generation under Cochrane criteria.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: Probably done — a random component (permuted blocks with randomly varying block sizes) is explicitly described, which meets the criteria for low risk of bias in sequence generation.
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Describes a random process (permuted blocks with random block sizes), satisfying low-risk criteria for sequence generation."}]
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Randomization procedure is reported but there is no information on central allocation, sealed envelopes, or other concealment; without such details, risk of selection bias due to possible foreknowledge cannot be assessed.
- Model support: Comment: Allocation method (permuted blocks stratified by site and age) is described, but the method used to conceal allocation prior to assignment is not reported, so it is unclear whether recruiters could foresee assignments.
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Describes random sequence generation but provides no information on how allocation was concealed prior to enrolment."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicitly indicates the key information for concealment is missing, preventing judgment of foreseeability of assignments."}]
- GT support: Details not provided
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The use of a matched placebo and explicit masking of clinicians (with separated blinded evaluating roles) makes it unlikely that lack of blinding influenced outcomes, so risk of performance bias is low.
- Model support: Quote: "Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications." Comment: Blinding of participants and personnel was probably effective because a matched placebo was used and treating/evaluating clinicians had defined blinded roles (evaluating clinician blinded to adverse events and trained to reliability). Probably done.
- Model support context: [{"source": "methodology", "quote": "Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "A matched placebo makes it unlikely participants could distinguish active drug from placebo, supporting participant blinding."}, {"source": "methodology", "quote": "Two masked clinicians met with participants... The evaluating clinician monitored efficacy and was blinded to adverse events.", "relevance": "Explicit masking of clinicians and separation of roles supports personnel/outcome assessment blinding."}]
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states that evaluating clinicians (outcome assessors) were masked and trained on the outcome instruments, making it unlikely that knowledge of allocation influenced outcome measurement, so risk of detection bias is low.
- Model support: Quote: "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events." Comment: Blinding of outcome assessment was implemented; evaluating clinicians were masked and trained on outcome measures, so detection bias is unlikely.
- Model support context: [{"source": "methodology", "quote": "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.", "relevance": "Shows outcome assessors were masked, reducing risk of detection bias."}, {"source": "methodology", "quote": "Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale...", "relevance": "Indicates standardized, reliable outcome assessment by blinded assessors."}]
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Attrition was moderate (~17%), balanced across arms with similar reasons, and analyses used ITT with LOCF. Although LOCF is a simple imputation, the modest and balanced missingness makes material bias unlikely, meeting criteria for Low risk.
- Model support: Quote: "Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. 'For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.'" Comment: Attrition was modest (about 17.4% overall), reasonably balanced between groups with similar reasons, and analyses used ITT with LOCF. Losses unlikely to introduce major bias given balance and similar reasons, so judged Low risk.
- Model support context: [{"source": "methodology", "quote": "Most participants (82.6%) completed the 12-week trial...12.3% stopped early due to adverse events...placebo group, 9.2% left early...another 6.6% withdrew consent.", "relevance": "Shows amount and reasons for missing data and balance across groups, relevant to attrition bias."}, {"source": "methodology", "quote": "\"For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.\"", "relevance": "Describes method used to handle missing data (LOCF) and that ITT principle was applied."}]
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Evidence row: {}
- Source context preview: 


## 20579848 - Palacios 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 59.54

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.
- `blinding_personnel`: Body weight was measured monthly ... by the CRC-trained personnel, who were blinded to the study treatments.
- `blinding_outcome_assessors`: Body weight was measured monthly ... by the CRC-trained personnel, who were blinded to the study treatments.
- `attrition_details`: Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. There were no significant...
- `study_design`: Single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial
- `additional_notes`: Interventions: high dairy group (four daily servings of low-fat dairy products, provided monthly), high elemental calcium group (calcium carbonate supplement 600 mg/d), control group (placebo tablet). Subjects instructed to maintain isocaloric diet and usual physical activity. Compliance monitored with monthly calendar, food records, FFQ, and 24-h recalls.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Low risk / Not applicable | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Not applicable / Unclear risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Although the study is described as randomized, there is no description of the random sequence generation method; without information that a random component (e.g., computer generator, random number table) was used, risk of bias for sequence generation is unclear.
- Model support: Comment: Randomization is claimed ("randomized"), but no method of sequence generation is reported in the paper. Probably not enough information to determine whether a truly random process was used.
- Model support context: [{"source": "methodology", "quote": "Single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial", "relevance": "States the study was randomized but gives no details on how the random sequence was generated."}, {"source": "methodology", "quote": "randomization_method: \"Not reported\"", "relevance": "Explicitly indicates the sequence generation method was not reported, preventing judgment of adequacy."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the paper does not describe how allocation was concealed (e.g. central randomization, sealed envelopes), there is insufficient information to judge whether enrolment staff could foresee assignments, so risk of bias is unclear.
- Model support: Comment: Allocation concealment method not reported in the article. Randomization is mentioned but no details on how assignments were concealed prior to enrolment, so risk of selection bias cannot be judged.
- Model support context: [{"source": "methodology", "quote": "randomization_method: \"Not reported\", allocation_concealment_method: \"Not reported\"", "relevance": "Direct statement that methods for randomization and concealment are not described."}, {"source": "methodology", "quote": "\"single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial\"", "relevance": "States trial was randomized and (double-)blind but provides no details on concealment procedures."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk / Not applicable
- Match: False
- Model rationale: Although assessors for weight were blinded, the methods note single-blinding for the dairy group and give no detail on who was blinded or how blinding was maintained; because participants likely knew dietary allocation (dairy foods vs pills) and details are insufficient, the potential for performance bias cannot be judged.
- Model support: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans." Comment: The report states double-blind but also notes the dairy group was single-blinded; it is unclear which participants/personnel were blinded and whether participants could infer allocation (food vs pills). Therefore risk of performance bias is unclear.
- Model support context: [{"source": "methodology", "quote": "single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial", "relevance": "States blinding but contradicts itself about dairy group, leaving uncertainty about participants/personnel blinding."}, {"source": "methodology", "quote": "Body weight ... measured ... by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "Indicates outcome assessors for weight were blinded, but does not clarify participant/personnel blinding relevant to performance bias."}]
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: Assessors of the primary objective outcome (body weight) were explicitly reported as blinded, and body weight is an objective measurement unlikely to be influenced by assessor knowledge, meeting criteria for low risk of detection bias.
- Model support: Quote: "Body weight was measured monthly ... by the CRC-trained personnel, who were blinded to the study treatments." Comment: The outcome assessors for key objective outcomes (body weight) were reported as blinded to treatment allocation, so detection bias for these outcomes is unlikely. Probably done.
- Model support context: [{"source": "methodology", "quote": "Body weight was measured monthly ... by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "States that outcome assessors were blinded, reducing risk of detection bias for measured outcomes."}, {"source": "methodology", "quote": "randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial", "relevance": "Indicates overall blinding procedures in trial design supporting assessor blinding."}]
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Not applicable / Unclear risk
- Match: True
- Model rationale: Although attrition was modest (5/30) and reasons were provided and reportedly similar, the paper does not report how missing outcome data were handled or present outcome data for dropouts, so it is insufficient to judge whether bias was introduced.
- Model support: Quote: "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Handling of missing data: Not reported." Comment: Although attrition is reported (5/30 dropped out, reasons given and reportedly similar baseline characteristics), the study does not report how missing outcome data were handled (no imputation/analysis details), nor...
- Model support context: [{"source": "methodology", "quote": "Five subjects dropped out from the study before the second visit... reasons: one medical, four lost interest... Of the 25 subjects who completed the study...", "relevance": "Gives numbers and reasons for attrition and balance across groups, but lacks handling of missing outcome data."}, {"source": "methodology", "quote": "Handling of missing data: Not reported.", "relevance": "Directly indicates absence of information on how missing outcome data were dealt with."}]
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Evidence row: {}
- Source context preview: 


## 21775755 - Ziegler 2011

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 56.46

### Methodology Extraction

- `randomization_method`: Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.
- `allocation_concealment_method`: The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_participants`: randomized, double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance
- `blinding_personnel`: double-blind ... The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_outcome_assessors`: Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners). Eligibility, baseline conditions, wave forms, stimulus response patterns, and test values were also...
- `attrition_details`: Not reported
- `study_design`: multicenter, randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial
- `additional_notes`: Trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week washout phase. An interim analysis was performed as soon as the 2-year data of most subjects were available; decision rules and alpha spending described. Randomized patients were additionally assigned a four-digit randomization number at baseline.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The allocation sequence was generated centrally by the Biostatistics Department and used block randomization, which is a described random method; this meets the Cochrane criteria for Low risk of bias in random sequence generation.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: Probably done — a centrally generated randomization list by a biostatistics department with block randomization constitutes a random sequence generation method and meets Low risk criteria.
- Model support context: [{"source": "methodology", "quote": "randomization list generated by the Biostatistics Department of MEDA Pharma; balanced using an undisclosed block size of six", "relevance": "Describes a random component (central computer/list and block randomization) supporting adequate sequence generation."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: While randomization was centrally generated, the report lacks explicit description that allocation was concealed from those enrolling participants (e.g. central telephone/web allocation or use of sequentially numbered opaque sealed envelopes). The presence of emergency sealed envelopes does not prove adequate concealment, so risk is unclear.
- Model support: Comment: Randomization list was generated centrally by the Biostatistics Department and patients received a four-digit randomization number; investigators received sealed envelopes for emergency decoding. However, there is no clear statement that allocation was concealed from enrolment staff (e.g. central allocation or that envelopes were sequentially numbered, opaque and inaccessible). Therefore allocation concealment cannot be confirmed.
- Model support context: [{"source": "methodology", "quote": "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma.", "relevance": "Shows random sequence was generated centrally but does not by itself prove concealment from recruiters/enrollers."}, {"source": "methodology", "quote": "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Indicates emergency decoding envelopes existed but does not confirm proper envelope safeguards or that enrolment staff could not foresee assignments."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is described as randomized double-blind with identical placebo tablets and sealed emergency code envelopes for investigators, so participants and key personnel were likely blinded and unlikely to have been able to infer assignments; therefore performance bias is likely low.
- Model support: Quote: "randomized, double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance" Comment: Blinding of participants and personnel was implemented with matching placebo tablets and described as double-blind; this makes it unlikely that knowledge of allocation biased outcomes. Probably done.
- Model support context: [{"source": "methodology", "quote": "randomized, double-blind, placebo-controlled ... film-coated tablets ... or matching placebo tablets ... that were identical in appearance", "relevance": "Direct evidence that participants received identical-appearing placebo and active tablets, supporting successful participant blinding."}, {"source": "methodology", "quote": "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Indicates investigators were kept blinded with emergency code-break procedure, supporting personnel blinding."}]
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Blinding was implemented for participants and personnel with identical placebo, and outcome measures were assessed by trained personnel with central independent evaluation, so detection bias is unlikely.
- Model support: Comment: The trial is described as randomized, double-blind, placebo-controlled with identical-appearing active and placebo tablets; outcome measurements (NIS, NSC, nerve conduction, QSTs, autonomic tests) were performed by trained and certified personnel and centrally read/QA'd by Reading and Quality Assurance Centers, making it unlikely that outcome assessment was biased by knowledge of allocation. Probably done.
- Model support context: [{"source": "methodology", "quote": "randomized, double-blind, placebo-controlled ... matching placebo tablets ... identical in appearance", "relevance": "Indicates participants and personnel were blinded, reducing likelihood assessors knew allocation."}, {"source": "methodology", "quote": "All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).", "relevance": "Central reading/QA of objective tests supports blinded, independent outcome assessment."}]
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: Because the report lacks any numbers, reasons, balance, or methods for handling missing outcome data, there is insufficient information to judge whether attrition could bias results; therefore the risk is unclear.
- Model support: Comment: Attrition details not reported in the available methods; insufficient information to assess amount, reasons, balance or handling of missing outcome data.
- Model support context: [{"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Directly indicates missing information about withdrawals, dropouts, and handling of incomplete data."}, {"source": "methodology", "quote": "Trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week washout phase.", "relevance": "Long follow-up increases risk of attrition, making reporting of missing data important but not provided."}]
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Evidence row: {}
- Source context preview: 


## 22928960 - Houry 2012

- Mode: strict
- Review context: none (0 chars)
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 51.51

### Methodology Extraction

- `randomization_method`: We used computer-generated randomization to assign new reviewers to either the intervention or control group.
- `allocation_concealment_method`: Not reported
- `blinding_participants`: All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.
- `blinding_personnel`: Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.
- `blinding_outcome_assessors`: Not reported
- `attrition_details`: Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees).
- `study_design`: Randomized controlled trial (individual randomization)
- `additional_notes`: Selection: enrolled consecutive individuals newly added to our reviewer ranks during the study period; no exclusion criteria. Intervention: mentors were senior journal reviewers (top 50 list criteria) paired to mentees reviewing the same manuscript; mentees asked to discuss their review with their mentor by email or telephone. Main outcomes: mean review quality rating score and slope in change in editor-assigned reviewer quality ratings from their first review until the end date of the study,...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Blinding of outcome assessment: All outcomes | Unclear risk | Unclear risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly reported using computer-generated randomization, which is an appropriate random method per Cochrane criteria, so risk of bias from sequence generation is low.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Probably done — a computer random number generator is a valid random component for sequence generation and meets the low-risk criteria.
- Model support context: [{"source": "methodology", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Direct statement that sequence was generated by a computer random method, indicating a truly random process."}, {"source": "methodology", "quote": "Randomized controlled trial (individual randomization)", "relevance": "Confirms individual random allocation consistent with the described computer-generated sequence."}]
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The study reports computer-generated randomization but provides no information on procedures to prevent foreknowledge of upcoming assignments (central allocation, sealed envelopes, etc.). Random sequence alone is insufficient to judge concealment, so risk is unclear.
- Model support: Comment: Allocation concealment not reported; computer-generated randomization was used but there is no information that enrolment staff could not foresee assignments, so concealment cannot be judged.
- Model support context: [{"source": "methodology", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Shows random sequence generation but gives no details on concealment before enrolment."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicitly indicates lack of information about how assignment was concealed."}]
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Reviewers operated under the journal's blinded peer-review process and editors recruiting reviewers were unaware of assignments; outcomes were editor-assigned quality ratings recorded in software and thus unlikely to be materially influenced by lack of further blinding, supporting Low risk.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Probably done — participants (reviewers) and personnel (editors) were operating within the journal's routine blinded peer-review process and editors invited reviewers without knowledge of group assignment; outcomes (editor-assigned reviewer quality ratings from software) are objective editorial scores and unlikely to be materially biased by lack of additional masking.
- Model support context: [{"source": "methodology", "quote": "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s...", "relevance": "Indicates routine blinding of reviewers that reduces participants' knowledge of allocation and potential bias."}, {"source": "methodology", "quote": "Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Suggests personnel making invitations were unaware of group assignment, reducing performance bias."}]
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: The report does not state whether editors who assigned reviewer quality ratings were blinded to reviewers' mentorship status. Because the outcomes are editor-assigned and could be influenced by knowledge of allocation, but no information is provided, the appropriate judgement is Unclear risk.
- Model support: Comment: Blinding of outcome assessment is not reported. Outcome assessors (editors assigning reviewer quality ratings) may or may not have been blinded to allocation; insufficient information to judge whether their knowledge could have influenced ratings.
- Model support context: [{"source": "methodology", "quote": "blinding_outcome_assessors: \"Not reported\"", "relevance": "Directly indicates no information provided about assessor blinding for reviewer quality ratings."}, {"source": "methodology", "quote": "Main outcomes: mean review quality rating score ... calculated from scores recorded in editorial management software.", "relevance": "Shows outcomes were editor-assigned ratings, which could be influenced by knowledge of allocation if not blinded."}]
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: There is some attrition and the authors report both per-protocol and an ITT analysis but do not present ITT results or sufficient detail on numbers randomized vs analyzed and reasons tied to outcomes; thus it is unclear whether missing data could bias results materially.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees)." Comment: Attrition is described and an ITT reportedly performed with similar results, but the ITT data are not shown, the amount of missing outcome data relative to randomized numbers is unclear, and reasons for non-contact may be related to outcomes. Therefore risk of bias from incomplete outcome data is unclear.
- Model support context: [{"source": "methodology", "quote": "Four subjects randomized to the mentorship group never made contact of any kind with their mentors... per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded...", "relevance": "Shows number and handling of missing data and that ITT results are not presented, limiting assessment of impact."}]
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Evidence row: {}
- Source context preview: 


## 23148458 - Sheridan 2012

- Mode: strict
- Review context: none (0 chars)
- Article chars: 34179
- Extraction context chars: 12003
- Total seconds: 49.97

### Methodology Extraction

- `randomization_method`: "Randomization used computer-generated random numbers that were sealed in opaque envelopes."
- `allocation_concealment_method`: "Randomization used computer-generated random numbers that were sealed in opaque envelopes."
- `blinding_participants`: Not reported
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)"
- `attrition_details`: Not reported
- `study_design`: Randomized controlled trials (two trials combined) — described as "we conducted two randomized controlled trials" and data presented combined
- `additional_notes`: Participants were randomized within practices. The patient intervention and accompanying surveys were delivered prior to scheduled appointments in a private room. Intervention groups: SDM interventions (video + coaching) vs highway safety control video (attention control). Physicians received a 1-hour educational session and were asked to complete a baseline questionnaire. Data combined from two trials conducted in different cities/practices; statistical considerations for combining data...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The extract explicitly reports a computer-generated random sequence, which meets the Cochrane criterion for low risk of bias in sequence generation (a valid random component was used).
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — a computer-generated random sequence is a valid random method for sequence generation and supports low risk of bias for randomization.
- Model support context: [{"source": "methodology", "quote": "\"Randomization used computer-generated random numbers that were sealed in opaque envelopes.\"", "relevance": "States the use of computer-generated random numbers, which is an adequate random sequence generation method."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The report states allocation used computer-generated random numbers sealed in opaque envelopes, which is an accepted method for preventing foreknowledge of assignments; therefore risk of selection bias from allocation concealment is low.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — allocation was concealed using opaque sealed envelopes, which prevents recruiters/enrollers from foreseeing assignments.
- Model support context: [{"source": "methodology", "quote": "\"Randomization used computer-generated random numbers that were sealed in opaque envelopes.\"", "relevance": "Describes the method used to conceal allocation, meeting criteria for adequate concealment."}, {"source": "methodology", "quote": "Participants were randomized within practices.", "relevance": "Context about who enrolled participants; supports relevance of proper concealment to prevent selection bias."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: There is insufficient information about whether participants or personnel were blinded; while physicians may not have known group assignment, participant blinding is unreported and delivery of different interventions (coaching vs control video) could have been apparent, so risk of performance bias cannot be judged.
- Model support: Comment: Blinding of participants and personnel is not reported. Participants received interventions (SDM video+coaching vs control video) prior to appointments, and physicians were notified of participation but not group assignment; however there is no direct statement that participants or personnel were blinded, so risk of performance bias cannot be determined.
- Model support context: [{"source": "methodology", "quote": "blinding_participants: \"Not reported\"; blinding_personnel: \"Not reported\"", "relevance": "Direct absence of reporting on participant and personnel blinding, central to performance bias judgment."}, {"source": "methodology", "quote": "Intervention groups: SDM interventions (video + coaching) vs highway safety control video (attention control). Physicians were notified only about patients’ participation, but not group assignment.", "relevance": "Describes delivery and suggests physicians may have been masked to assignment, but does not confirm participant or personnel blinding."}]
- GT support: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The methodology states physicians were notified only of participation and not group assignment, indicating blinding of outcome assessors; therefore detection bias from assessor knowledge is unlikely.
- Model support: Quote: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)" Comment: This indicates outcome assessors (physicians) were not informed of group assignment. Probably done — outcome assessment was unlikely to be influenced by knowledge of allocation.
- Model support context: [{"source": "methodology", "quote": "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)", "relevance": "Shows physicians (outcome assessors) were blinded to group assignment."}, {"source": "methodology", "quote": "Intervention groups: SDM interventions (video + coaching) vs highway safety control video (attention control).", "relevance": "Outcomes likely include patient-reported decision measures; physician blinding reduces assessor-related detection bias."}]
- GT support: Self‐reported outcome measures, therefore, low risk considering masking of participants.
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: There is no information on numbers lost to follow-up, reasons for missing data, or methods for handling missing outcomes. Under Cochrane criteria, insufficient reporting requires an 'Unclear risk' judgement.
- Model support: Comment: Attrition and handling of missing data are not reported in the extracted methods; insufficient information to judge whether missing outcome data could bias results.
- Model support context: [{"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Directly indicates missing information about losses to follow-up and handling of incomplete data."}, {"source": "methodology", "quote": "Data presented combined from two trials; details for combining described in methods (details not provided in excerpt).", "relevance": "Combining trials without reported attrition raises uncertainty about balance and handling of missing data across groups."}]
- GT support: SeeFigure 1for reporting on missing data (only 2 participants in intervention group due to false inclusion)
- Evidence row: {}
- Source context preview: 

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.